Search Results - "MIZUSHIMA, Tomoko"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities by Umemura, Ken, Mizushima, Tomoko, Katayama, Hajime, Kiryu, Yoshimitsu, Yamori, Takao, Andoh, Toshiwo

    Published in Molecular pharmacology (01-10-2002)
    “…DNA topoisomerases (topos) I and II are molecular targets of several potent anticancer agents. Thus inhibitors of these enzymes are potential candidates or…”
    Get more information
    Journal Article
  3. 3

    Efficient production of recombinant adeno-associated viral vector, serotype DJ/8, carrying the GFP gene by Hashimoto, Haruo, Mizushima, Tomoko, Chijiwa, Tsuyoshi, Nakamura, Masato, Suemizu, Hiroshi

    Published in Virus research (15-06-2017)
    “…•AAV, Serotype DJ/8 produced by the combination of lipofectamine and iodixanol produces is an efficient yield.•AAV, Serotype DJ/8 carrying GFP gene is produced…”
    Get full text
    Journal Article
  4. 4

    Establishing EGFP Congenic Mice in a NOD/Shi-scid IL2Rgnull (NOG) Genetic Background Using a Marker-Assisted Selection Protocol (MASP) by SUEMIZU, Hiroshi, YAGIHASHI, Chie, MIZUSHIMA, Tomoko, OGURA, Tomoyuki, ETOH, Tomoo, KAWAI, Kenji, ITO, Mamoru

    Published in Experimental Animals (2008)
    “…Severely immunocompromised NOD/Shi-scid IL2Rg null (NOG) mice, which show higher engraftment efficiency, are useful as recipients in xenotransplantation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Fatty Acid β-Oxidation-dependent and -independent Responses and Tumor Aggressiveness Acquired Under Mild Hypoxia by Wakui, Masatoshi, Kawai, Kenji, Mizushima, Tomoko, Nishime, Chiyoko, Serizawa, Akihiko, Suemizu, Hiroshi, Asakura, Keisuke, Yamauchi, Yoshikane, Hayashida, Tetsu, Suematsu, Makoto, Murata, Mitsuru

    Published in Anticancer research (01-01-2019)
    “…The present study assessed whether and how tumor cells undergoing hypoxia contribute to disease progression after moving to areas with different oxygen…”
    Get full text
    Journal Article
  7. 7

    Study on AAV-mediated gene therapy for diabetes in humanized liver mouse to predict efficacy in humans by Hashimoto, Haruo, Mizushima, Tomoko, Ogura, Tomoyuki, Kagawa, Takahiro, Tomiyama, Kayo, Takahashi, Ri-ichi, Yagoto, Mika, Kawai, Kenji, Chijiwa, Tsuyoshi, Nakamura, Masato, Suemizu, Hiroshi

    “…Most in vivo studies on the conversion to insulin-producing cells with AAV carrying PDX1 gene are performed in rodents. However, there is little information…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Abstract 456: Adaptation of cancer cells to hypoxic environments for tumor progression by Mizushima, Tomoko, Kawai, Kenji, Nishime, Chiyoko, Ohmura, Mitsuyo, Hayakawa, Eri, Matsuyama, Masahiro, Asakura, Keisuke, Izumi, Yotaro, Suemizu, Hiroshi, Ohnishi, Yasuyuki, Nakamura, Masato, Suematsu, Makoto, Wakui, Masatoshi

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…There have been a number of reports mentioning the significance of adaptation of cancer cells to hypoxic environments in tumor growth, invasion, and…”
    Get full text
    Journal Article
  11. 11

    Metabolomic profiling of the liver bearing human colon cancer metastasis in superimmunodeficient NOG mice by Ohmura, Mitsuyo, Handa, Kan, Nishime, Chiyoko, Mizushima, Tomoko, Kawai, Kenji, Hishiki, Takako, Yamamoto, Takehiro, Wakui, Masatoshi, Suemizu, Hiroshi, Nakamura, Masato, Suematsu, Makoto

    Published in The FASEB journal (01-04-2010)
    “…Hypoglycemia is one of the important events in paraneoplastic syndrome caused by solid tumors. Although metabolic feature of solid tumors characterized by…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Establishing EGFP congenic mice in a NOD/Shi-scid IL2Rg(null) (NOG) genetic background using a marker-assisted selection protocol (MASP) by Suemizu, Hiroshi, Yagihashi, Chie, Mizushima, Tomoko, Ogura, Tomoyuki, Etoh, Tomoo, Kawai, Kenji, Ito, Mamoru

    Published in Experimental animals (01-10-2008)
    “…Severely immunocompromised NOD/Shi-scid IL2Rg (null) (NOG) mice, which show higher engraftment efficiency, are useful as recipients in xenotransplantation…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Establishing EGFP Congenic Mice in a NOD/Shi-scid IL2Rg super(null) (NOG) Genetic Background Using a Marker-Assisted Selection Protocol (MASP) by Suemizu, Hiroshi, Yagihashi, Chie, Mizushima, Tomoko, Ogura, Tomoyuki, Etoh, Tomoo, Kawai, Kenji, Ito, Mamoru

    Published in Experimental animals (01-01-2008)
    “…Severely immunocompromised NOD/Shi-scid IL2Rg super(null) (NOG) mice, which show higher engraftment efficiency, are useful as recipients in xenotransplantation…”
    Get full text
    Journal Article